Proteome profiling to advance management of metabolic dysfunction-associated fatty liver disease

被引：0
|
作者：
Eslam, Mohammed [1 ,2 ]
Mendez-Sanchez, Nahum [3 ]
Zheng, Ming-Hua [4 ,5 ,6 ]
机构：
[1] Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, 176 Hawkesbury Rd, Sydney, NSW 2145, Australia
[2] Univ Sydney, 176 Hawkesbury Rd, Sydney, NSW 2145, Australia
[3] Med Clin Fdn, Liver Res Unit, Mexico City, DF, Mexico
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, NAFLD Res Ctr, Wenzhou, Peoples R China
[5] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[6] Key Lab Diag & Treatment Dev Chron Liver Dis Zhej, Wenzhou, Peoples R China
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2024年 / 13卷 / 01期
基金：
英国医学研究理事会;
关键词：
Metabolic dysfunction-associated fatty liver disease (MAFLD); fatty liver disease (FLD); fibrosis; proteome; biomarkers;
D O I：
10.21037/hbsn-23-596
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：147 / 149
页数：3
相关论文
共 50 条
  • [1] Deep proteome profiling of metabolic dysfunction-associated steatotic liver disease
    Boel, Felix
    Akimov, Vyacheslav
    Teuchler, Mathias
    Terkelsen, Mike Krogh
    Wernberg, Charlotte Wilhelmina
    Larsen, Frederik Tibert
    Hallenborg, Philip
    Lauridsen, Mette Munk
    Krag, Aleksander
    Mandrup, Susanne
    Ravnskjaer, Kim
    Blagoev, Blagoy
    COMMUNICATIONS MEDICINE, 2025, 5 (01):
  • [2] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [3] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [4] LIVER FIBROSIS IN ASIANS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE
    Kim, Byung Ik
    Sohn, Won
    Kwon, Heon-Ju
    Cho, Yong Kyun
    HEPATOLOGY, 2021, 74 : 1022A - 1022A
  • [5] Liver Fibrosis in Asians With Metabolic Dysfunction-Associated Fatty Liver Disease
    Sohn, Won
    Kwon, Heon-Ju
    Chang, Yoosoo
    Ryu, Seungho
    Cho, Yong Kyun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : E1135 - E1148
  • [6] Metabolic dysfunction-associated fatty liver disease: a year in review
    Alharthi, Jawaher
    Gastaldelli, Amalia
    Cua, Ian Homer
    Ghazinian, Hasmik
    Eslam, Mohammed
    CURRENT OPINION IN GASTROENTEROLOGY, 2022, 38 (03) : 251 - 260
  • [7] Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
    Feng, Gong
    Byrne, Christopher D.
    Targher, Giovanni
    Wang, Fudi
    Zheng, Ming-Hua
    LIVER INTERNATIONAL, 2022, 42 (07) : 1496 - 1502
  • [8] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Bhopale, Kamlesh K.
    Srinivasan, Mukund P.
    LIVERS, 2023, 3 (04): : 597 - 617
  • [9] Therapeutic developments in metabolic dysfunction-associated fatty liver disease
    Shi Yiwen
    Fan Jiangao
    中华医学杂志英文版, 2022, 135 (09) : 1009 - 1018
  • [10] Therapeutic developments in metabolic dysfunction-associated fatty liver disease
    Shi, Yiwen
    Fan, Jiangao
    CHINESE MEDICAL JOURNAL, 2022, 135 (09) : 1009 - 1018
12345